Treatment success rate for patients treated for MDR-TB in Bosnia and Herzegovina
Bosnia and Herzegovina: Treatment success rate for patients treated for MDR-TB was 33.0% in 2022. ▼ Falling
Latest (2022)
33.0%
World rank
151st
of 163 countries
All-time high
100.0%
in 2009
All-time low
20.0%
in 2011
Years of data
8
2009–2022
Treatment success rate for patients treated for MDR-TB in Bosnia and Herzegovina, 2009–2022
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for treatment success rate for patients treated for mdr-tb in Bosnia and Herzegovina is 33.0%, measured in 2022.
That represents a change of down 23.3% over ten years.
Over the whole period, treatment success rate for patients treated for mdr-tb in Bosnia and Herzegovina peaked at 100.0% in 2009 and was at its lowest, 20.0%, in 2011.
Bosnia and Herzegovina ranks 151st of 163 countries on this measure, in the bottom quarter.
Treatment success rate for patients treated for MDR-TB in Bosnia and Herzegovina, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 100.0% | — |
| 2010 | 57.0% | -43.0% |
| 2011 | 20.0% | -64.9% |
| 2012 | 43.0% | +115.0% |
| 2013 | 100.0% | +132.6% |
| 2014 | 67.0% | -33.0% |
| 2015 | 100.0% | +49.3% |
| 2022 | 33.0% | -67.0% |
Bosnia and Herzegovina compared with similar countries
- Bosnia and Herzegovina's 33.0% is below the median for upper middle income countries, which is 70.0%, 47% of the median. (47 countries reporting)
- Bosnia and Herzegovina's 33.0% is below the median for Europe & Central Asia, which is 68.0%, 49% of the median. (41 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 100.0% | 1 |
| 2010s | 64.5% | 20.0% | 100.0% | 6 |
| 2020s | 33.0% | 33.0% | 33.0% | 1 |
Countries ranked near Bosnia and Herzegovina
- 149 Bolivia, Plurinational State of 42.0% compare
- 150 Singapore 39.0% compare
- 151 Papua New Guinea 33.0% compare
- 151 Guyana 33.0% compare
- 151 Trinidad and Tobago 33.0% compare
More health data for Bosnia and Herzegovina
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.071 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,689 deaths per 1,000 people (2090)
- Number of infants who die before age 1 11 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.62 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.019 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.62 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is treatment success rate for patients treated for mdr-tb in Bosnia and Herzegovina?
- Treatment success rate for patients treated for mdr-tb in Bosnia and Herzegovina was 33.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate for patients treated for mdr-tb recorded in Bosnia and Herzegovina?
- The highest recorded value was 100.0% in 2009.
- What is the lowest treatment success rate for patients treated for mdr-tb recorded in Bosnia and Herzegovina?
- The lowest recorded value was 20.0% in 2011.
- How does Bosnia and Herzegovina rank for treatment success rate for patients treated for mdr-tb?
- Bosnia and Herzegovina ranks 151st out of 163 countries with data for 2022.
- Is treatment success rate for patients treated for mdr-tb rising or falling in Bosnia and Herzegovina?
- Over the last ten years it is down 23.3%. The long-run trend across the full record is falling.
- Where does this Bosnia and Herzegovina data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).